Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart Cart lightblue
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Locations


Orders Processing,
Shipping & Receiving,
Warehouse

2 Shaker Rd Suites
B001/B101
Shirley, MA 01464


Production Lab

Floor 6, Suite 620
20700 44th Avenue W
Lynnwood, WA 98036

Telephone Numbers



Tel: +1 (206) 374-1102
Fax: +1 (206) 577-4565

Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Catalog Number Size Price
LS-G15342-10 10 µg $287 
LS-G15342-50 50 µg $482 
LS-G15342-100 100 µg $770 
LS-G15342-200 200 µg $962 
LS-G15342-500 500 µg $1,623 
LS-G15342-1 1 mg $2,094 
LS-G15342-2 2 mg $2,284 
LS-G15342-5 5 mg $3,361 
KIR2DS2 / CD158j Protein - Recombinant Killer Cell Immunoglobulin Like Receptor 2DS2 By SDS-PAGE

Human KIR2DS2 / CD158j Protein (Recombinant His-GST) (aa22-304) - LS-G15342

Human KIR2DS2 / CD158j Protein (Recombinant His-GST) (aa22-304) - LS-G15342

Description:
KIR2DS2 / CD158j Protein LS-G15342 is a Recombinant Human KIR2DS2 / CD158j produced in E. coli aa 22-304 of P43631 with His-GST tag(s). For Research Use Only
Price
Catalog Number
$287
LS-G15342-10
Toll Free North America
206-374-1102
For Research Use Only

Overview

Description:
KIR2DS2 / CD158j Protein LS-G15342 is a Recombinant Human KIR2DS2 / CD158j produced in E. coli aa 22-304 of P43631 with His-GST tag(s). For Research Use Only

Specifications

Type
Recombinant Protein
Target
KIR2DS2 / CD158j
Synonyms
KIR2DS2 | 1060P11.9.2 | 183ActI | CD158j antigen | CD158J | Killer-cell Ig-like receptor | MHC class I NK cell receptor | NK receptor 183 ActI | p58 KIR | p58 NK receptor CL-49 | Cl-49 | NKAT-5 | NKAT5
Species
Human
Modifications
Unmodified
Conjugations
Unconjugated
Tag
His-GST
Region
aa 22-304 of P43631
Predicted Molecular Weight
62.9 kDa
Expression System
E. coli
Source Species
E. coli
Purification
Greater than 95%
Bio-Activity
Not Tested
Endotoxin
Not Tested
Presentation
Lyophilized from 20mM Tris, 150mM NaCl, pH 8.0, containing 1mM EDTA, 1mM DTT, 0.01% sarcosyl, 5% trehalose, and Proclin300
Reconstitution
Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/ml. Do not vortex.
Storage
Store at 4°C for up to 1 month, or aliquot and store at -80°C for up to 1 year. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This protein carries the LSBio 100% Guarantee.
LSBio Guarantee
About KIR2DS2 / CD158j
P43631 NM_012312 NP_036444.1

Publications (0)

Customer Reviews (0)

Images

Sodium Dodecyl Sulfate - Polyacrylamide Gel Electrophoresis

KIR2DS2 / CD158j Protein - Recombinant Killer Cell Immunoglobulin Like Receptor 2DS2 By SDS-PAGE
Recombinant Killer Cell Immunoglobulin Like Receptor 2DS2 By SDS-PAGE

Sodium Dodecyl Sulfate - Polyacrylamide Gel Electrophoresis

KIR2DS2 / CD158j Protein - Recombinant Killer Cell Immunoglobulin Like Receptor 2DS2 By SDS-PAGE
Recombinant Killer Cell Immunoglobulin Like Receptor 2DS2 By SDS-PAGE

Sodium Dodecyl Sulfate - Polyacrylamide Gel Electrophoresis

KIR2DS2 / CD158j Protein - Recombinant Killer Cell Immunoglobulin Like Receptor 2DS2 By SDS-PAGE
Recombinant Killer Cell Immunoglobulin Like Receptor 2DS2 By SDS-PAGE

Sodium Dodecyl Sulfate - Polyacrylamide Gel Electrophoresis

KIR2DS2 / CD158j Protein - Recombinant Killer Cell Immunoglobulin Like Receptor 2DS2 By SDS-PAGE
Recombinant Killer Cell Immunoglobulin Like Receptor 2DS2 By SDS-PAGE

Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at:

Technical.Support@LSBio.com

Requested From: United States
Date Requested: 7/13/2024